PML suppresses IL-6-induced STAT3 activation by interfering with STAT3 and HDAC3 interaction.

Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3.

Inhibition of STAT3 activation by KT-18618 via the disruption of the interaction between JAK3 and STAT3.

CUEDC2 suppresses glioma tumorigenicity by inhibiting the activation of STAT3 and NF-κB signaling pathway.

Shikonin inhibits IFN-γ-induced K17 over-expression of HaCaT cells by interfering with STAT3 signaling.

Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts.

Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.

Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.

Interferon-γ suppresses intestinal epithelial aquaporin-1 expression via Janus kinase and STAT3 activation.

miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.

Stat3 activation in murine colitis induced by enterotoxigenic Bacteroides fragilis.

Stat3 inhibits Beclin 1 expression through recruitment of HDAC3 in nonsmall cell lung cancer cells.

PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.

Electrochemical detection of the Fc-STAT3 phosphorylation and STAT3-Fc-STAT3 dimerization and inhibition.

miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.

FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.

MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.

Decreased expression and activation of Stat3 in severe preeclampsia.

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications.

Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.

miR-17-92 clusters.

Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.

STAT3 activation and risk of recurrence in meningiomas.

Inhibition of STAT3 reduces astrocytoma cell invasion and constitutive activation of STAT3 predicts poor prognosis in human astrocytoma.

Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling.

Suggest Documents

Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3.

Inhibition of STAT3 activation by KT-18618 via the disruption of the interaction between JAK3 and STAT3.

CUEDC2 suppresses glioma tumorigenicity by inhibiting the activation of STAT3 and NF-κB signaling pathway.

Shikonin inhibits IFN-γ-induced K17 over-expression of HaCaT cells by interfering with STAT3 signaling.

Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts.

Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.

Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.

Interferon-γ suppresses intestinal epithelial aquaporin-1 expression via Janus kinase and STAT3 activation.

miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.

Stat3 activation in murine colitis induced by enterotoxigenic Bacteroides fragilis.

Stat3 inhibits Beclin 1 expression through recruitment of HDAC3 in nonsmall cell lung cancer cells.

PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.

Electrochemical detection of the Fc-STAT3 phosphorylation and STAT3-Fc-STAT3 dimerization and inhibition.

miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.

FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.

MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.

Decreased expression and activation of Stat3 in severe preeclampsia.

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications.

Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.

miR-17-92 clusters.

Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.

STAT3 activation and risk of recurrence in meningiomas.

Inhibition of STAT3 reduces astrocytoma cell invasion and constitutive activation of STAT3 predicts poor prognosis in human astrocytoma.

Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling.

PML suppresses IL-6-induced STAT3 activation by interfering with STAT3 and HDAC3 interaction.

Recommend Documents

Follow Us